Philips (PHG) plans to invest over $150M in U.S. manufacturing and R&D, expanding production of its AI-enabled ultrasound systems. Global Chief Operations Officer Wim Appelo joins to discuss the investment, which takes Philips' total U.S. investment to over $1B/year. Appelo highlights how AI integration in ultrasounds drives efficiency and capability, particularly in diagnosing coronary artery disease and cardiovascular issues. The investment is expected to create over 100 new jobs in Pennsylvania.